TAMs are often identified by CD11b and CD68, with markers such as IFN-γ and HLA-DR associated with an anti-tumor phenotype, while CD163, CD206, PD-L1 and ARG1 are associated with a tumor-promoting phenotype.15 Here, IFNG is linked to neoplasm.